Clinical research blog
Explore our blog for insights into the big questions in precision medicine and clinical research.
Trial sponsors often assume that site enablement is largely complete once a trial launches. Feasibility assessments, training materials, and startup timelines a...
Continue reading
Cell and gene therapy continues to advance across a growing number of rare genetic conditions. As more of these therapies move closer to the clinic, a central t...
Continue reading
Participation in clinical trials can be burdensome and disruptive. In addition to practical inconveniences and discomfort, participants may have to take time of...
Continue reading
Advocating for patients is one of the core pillars of Sano’s mission. Our approach to clinical trials is patient-centered and entails deep and meaningful engage...
Continue reading
Rare disease trials are among the most challenging to design and execute. Patient populations are small and hard to reach, and personal and disease-related burd...
Continue reading
At this year’s DPHARM conference, Sano’s VP of Commercial, Ben Jackson, joined a panel on clinical trial patient matching moderated by a clinical expert from No...
Continue reading
At Sano Genetics, our mission is to make clinical research in precision medicine faster, more inclusive, and more efficient. In our Q2 2025 product webinar, we ...
Continue reading
Site disengagement can be a major barrier to successful and timely trial execution. A significant contributor to disengagement is overloading sites with redunda...
Continue reading
Clinical trial recruitment is notoriously difficult, and nowhere is this more acute than at the referral stage. When a participant who looks potentially eligibl...
Continue reading
While there have been significant strides in the development of drugs for rare diseases over the past few decades, only 5% of rare diseases have FDA-approved tr...
Continue reading